These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30197188)

  • 41. Sustained ocular hypertension following intravitreal injections of 0.5 mg/0.05 ml ranibizumab.
    Loukianou E; Brouzas D; Apostolopoulos M
    Int Ophthalmol; 2011 Jun; 31(3):211-3. PubMed ID: 21611879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
    Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD36 gene is associated with intraocular pressure elevation after intravitreal application of anti-VEGF agents in patients with age-related macular degeneration: Implications for the safety of the therapy.
    Matušková V; Balcar VJ; Khan NA; Bonczek O; Ewerlingová L; Zeman T; Kolář P; Vysloužilová D; Vlková E; Šerý O
    Ophthalmic Genet; 2018; 39(1):4-10. PubMed ID: 28557591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
    El Chehab H; Le Corre A; Giraud JM; Ract-Madoux G; Swalduz B; Dot C
    J Fr Ophtalmol; 2012 Oct; 35(8):614-21. PubMed ID: 22832030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration.
    Wen JC; Reina-Torres E; Sherwood JM; Challa P; Liu KC; Li G; Chang JY; Cousins SW; Schuman SG; Mettu PS; Stamer WD; Overby DR; Allingham RR
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1893-1898. PubMed ID: 28358961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of ocular hypertension after anti-VEGF injections: examining the effect of drug filtration and silicone-free syringes.
    Bae SS; Koenigstein D; Weaver T; Merkur A; Albiani D; Pakzad-Vaezi K; Kirker A
    Can J Ophthalmol; 2023 Feb; 58(1):66-72. PubMed ID: 34331870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of axial length and postinjection reflux on sustained intraocular pressure elevation as a result of intravitreal anti-vascular endothelial growth factor therapy.
    Hoang QV; Jung JJ; Mrejen S; Freund KB
    Retina; 2014 Mar; 34(3):519-24. PubMed ID: 24240557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab.
    Freund KB; Hoang QV; Saroj N; Thompson D
    Ophthalmology; 2015 Sep; 122(9):1802-10. PubMed ID: 26025097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraocular pressure trends after intravitreal injections of anti-vascular endothelial growth factor agents for diabetic macular edema.
    Al-Abdullah AA; Nowilaty SR; Asghar N; Al-Kharashi AS; Ghazi NG
    Retina; 2015 Mar; 35(3):440-8. PubMed ID: 25285810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
    Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
    Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H
    Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does intravitreal injections of bevacizumab for age-related macular degeneration affect long-term intraocular pressure?
    Kim D; Nam WH; Kim HK; Yi K
    J Glaucoma; 2014 Sep; 23(7):446-8. PubMed ID: 23632401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-Term Effect of Anti-VEGF Agents on Intraocular Pressure in Age-Related Macular Degeneration.
    Beato J; Pedrosa AC; Pinheiro-Costa J; Freitas-da-Costa P; Falcão MS; Melo A; Estrela-Silva S; Falcão-Reis F; Carneiro ÂM
    Ophthalmic Res; 2016; 56(1):30-4. PubMed ID: 27046391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
    Yamamoto Y; Komatsu T; Koura Y; Nishino K; Fukushima A; Ueno H
    Can J Ophthalmol; 2008 Feb; 43(1):42-7. PubMed ID: 18204501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The link between intravitreal antivascular endothelial growth factor injections and glaucoma.
    SooHoo JR; Seibold LK; Kahook MY
    Curr Opin Ophthalmol; 2014 Mar; 25(2):127-33. PubMed ID: 24406814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery.
    Eadie BD; Etminan M; Carleton BC; Maberley DA; Mikelberg FS
    JAMA Ophthalmol; 2017 Apr; 135(4):363-368. PubMed ID: 28301639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure.
    Nariani A; Williams B; Hariprasad SM
    Indian J Ophthalmol; 2016 Sep; 64(9):643-647. PubMed ID: 27853011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab.
    Lee JW; Park H; Choi JH; Lee HJ; Moon SW; Kang JH; Kim YG
    BMC Ophthalmol; 2016 May; 16():69. PubMed ID: 27245159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. INCIDENCE OF SUSTAINED OCULAR HYPERTENSION USING PREPACKAGED VERSUS FRESHLY PREPARED INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Storey PP; Ho V; Yeh S; Reddy S; Fang-Yen NH; Pequignot E; Leiby BE; Fineman M; Garg S; Hubbard GB; Hsu J
    Retina; 2015 Oct; 35(10):1992-2000. PubMed ID: 26035396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis.
    Zhou Y; Zhou M; Xia S; Jing Q; Gao L
    Sci Rep; 2016 Dec; 6():39301. PubMed ID: 28000707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.